Ocuphire Pharma Inc

NASDAQ:OCUP  
3.11
+0.30 (+10.64%)
3:35:37 PM EDT: $3.16 +0.05 (+1.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)71.57M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$28.06 Million
Adjusted EPS$0.72
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Ocuphire Pharma Inc Stock, NASDAQ:OCUP

37000 Grand River Avenue, Suite 120, Farmington Hills, Michigan 48335
United States of America
Phone: +1.248.681.9815
Number of Employees: 9

Description

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.